An interventional study of Extended information on side effects in Vaccination, sponsored by University of Auckland, New Zealand. Completed at 1 site in New Zealand. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2012-07-30.
Sponsored by University of Auckland, New Zealand · Not applicable, Interventional, and Health services research
This study aims to investigate the effect of providing additional information about possible mild side effects of the yellow fever vaccination on the reporting of physical symptoms. Additionally, the project aims to investigate the relationship between individual characteristics (trait anxiety and perceived sensitivity to medication) and the reporting of physical symptoms, as well as possible interactions between the level of information provided and individual characteristics. We hypothesize that more information about mild symptoms provided to participants will increase the number of reported symptoms after vaccination.
60 studies on the registry are indexed under Yellow Fever; 12 are open to participants now.
This study's enrollment of 100 is close to the median of 110 across 48 interventional studies indexed under Yellow Fever.
Browse Yellow Fever studies →University of Auckland, New Zealand is the lead sponsor of 57 studies on the registry; 13 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Provision of extended symptom side effects information
Behavioral: Extended information on side effects
Standard information on side effects
More detailed information on possible side effects of vaccine
symptom report scale
Time frame: 20 minutes and 1 week post vaccination
patient satisfaction scale
Time frame: 20 minutes and 1 week post vaccination
This study is completed, as verified in Jul 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Auckland, New Zealand